Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuation trial of Herceptin (trastuzumab) in patients with HER2 overexpressing tumors
2007-000348-28Phase 4Completed
- Sponsor
- Roche
- Start
- Jul 2007
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of trastuzumab in Nonhematologic neoplasms, sponsored by Roche. Primary endpoint: Provision of Herceptin after completion of prior trials. Started Jul 2007; status: completed.
02
Drugs
03
Conditions
Nonhematologic neoplasms
Beyond the preview
Go deeper on 2007-000348-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000348-28.